Ethyl 2-(2-((tert-butoxycarbonyl)amino)thiazol-3(2H)-yl)acetate

Catalog No. :
ACVBLO393
CAS No. :
82548-78-5
Molecular Formula :
C12H20N2O4S
Molecular Weight :
288.37

IUPAC Name:ethyl 2-(2-((tert-butoxycarbonyl)amino)thiazol-3(2H)-yl)acetate

Ethyl 2-(2-((tert-butoxycarbonyl)amino)thiazol-3(2H)-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$748.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(2-((tert-butoxycarbonyl)amino)thiazol-3(2H)-yl)acetate
IUPAC Nameethyl 2-(2-((tert-butoxycarbonyl)amino)thiazol-3(2H)-yl)acetate
MDL No.MFCD28013982
Molecular FormulaC12H20N2O4S
Molecular Weight288.37
SMILESCCOC(=O)CN1C=CSC1NC(=O)OC(C)(C)C
InChI KeyOQEYCSMEOLCRHS-UHFFFAOYSA-N
SynonymEthyl (2-Boc-amino-thiazole-3-yl)acetate;ETHYL 2-(2-([(TERT-BUTOXY)CARBONYL]AMINO)-1,3-THIAZOL-4-YL)ACETATE;ethyl {2-[(tert-butoxycarbonyl)amino]-1,3-thiazol-4-yl}acetate;4-Thiazoleacetic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-, ethyl ester;Ethyl 2-(2-((tert-butoxycarbonyl)amino)thiazol-4-yl)acetate
CAS No.82548-78-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVBLO393 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVBLO393 route product structure diagram
    ACVBLO39382548-78-5
Inquiry

2. ACVBLO393 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVBLO393 route product structure diagram
    ACVBLO39382548-78-5
Inquiry

Comments (0)